Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06225492 · ClinicalTrials.gov registry record · Phase 4
DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands
A Phase 4 study, sponsored by Main Line Center for Laser Surgery.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT06225492 is a Phase 4 study that has completed, run by Main Line Center for Laser Surgery. The registered enrollment target is 20 participants.
The verdict
NCT06225492, a Phase 4 study, has completed, sponsored by Main Line Center for Laser Surgery.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study seeks to evaluate the effectiveness and duration of action of DaxibotulinumtoxinA for neck rejuvenation through treatment of platysmal bands. This study will consist of one treatment visit with subjects being randomized to receiving 15 or 20 units of DaxibotulinumtoxinA per platysmal band. Subjects will return for 5 follow-up visits at 8, 12, 16, 20, and 24 weeks for evaluation.
Interventions
- DRUG DaxibotulinumtoxinA 15 units
- DRUG DaxibotulinumtoxinA 20 units
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2025-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06225492
The ClinicalTrials.gov registry entry for NCT06225492 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Main Line Center for Laser Surgery, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DaxibotulinumtoxinA 15 units is the first listed.
NCT06225492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06225492 about?
NCT06225492 is a clinical study titled "DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands". This study seeks to evaluate the effectiveness and duration of action of DaxibotulinumtoxinA for neck rejuvenation through treatment of platysmal bands. This study will consist of one treatment visit with subjects being randomized to receiving 15 or 20 units of DaxibotulinumtoxinA per platysmal band...
What is the current status of trial NCT06225492?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2024-01-01. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT06225492?
The interventions under investigation include: DaxibotulinumtoxinA 15 units (DRUG), DaxibotulinumtoxinA 20 units (DRUG).
Who is sponsoring clinical trial NCT06225492?
This trial is sponsored by Main Line Center for Laser Surgery, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.